AI Science Tracker

Deep-learning-guided cell-free screening identifies antimicrobial peptides

Max Planck Institute for Terrestrial Microbiology; Goethe University Frankfurt; Philipps University of Marburg · 8 Nov 2023 · biology

Discovery

Deep-learning-guided cell-free screening identifies antimicrobial peptides

Generative and predictive deep-learning models proposed and prioritized peptide sequences for cell-free synthesis and screening. The authors report 30 functional antimicrobial peptides among 500 candidates tested across five design–build–test rounds. The assay tested peptides in unpurified cell-free mixtures, a limitation for interpreting activity and potency. The reported effects do not establish clinical efficacy or antibiotic approval.

Technology: Variational autoencoders; convolutional and recurrent neural-network regressors

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: 500 model-prioritized candidates were produced and screened; 30 showed functional antimicrobial activity in the reported assays.
  • Still unknown: Unpurified CFPS assay mixtures, animal/human efficacy and independent replication limit interpretation.
  • AI role: Generative models proposed peptide sequences and learned regressors prioritized candidates before cell-free synthesis and activity tests.

Evidence sources: https://pubmed.ncbi.nlm.nih.gov/37938588/ · https://pmc.ncbi.nlm.nih.gov/articles/PMC10632401/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 16 Nov 2026. Review scope: Primary PubMed record, abstract and figure captions; indexed full-text results for assay conditions..

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.